Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVF plus non-cross-linked hyaluronic acid versus PRP plus non-cross-linked hyaluronic acid after fractional CO2 laser for atrophic acne scars
IRCT20260802070498N1Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Sep 2026
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of autologous adipose stromal vascular fraction, platelet-rich plasma and hyaluronic acid in atrophic acne scar (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Improvement of atrophic acne scars based on clinical evaluation and Patient satisfaction with treatment outcome. Started Sep 2026; status: completed.
02
Drugs
autologous adipose stromal vascular fractionplatelet-rich plasmahyaluronic acid
03
Conditions
atrophic acne scar
Beyond the preview
Go deeper on IRCT20260802070498N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260802070498N1.